EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Gross Margin (QoQ) (2018 - 2026)

Analysis

EyePoint (EYPT) Gross Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,586.00
Mar 31, 2026 -1,538.00
Dec 31, 2025 1,415.00
Sep 30, 2025 -7,154.00
Jun 30, 2025 20.00
Mar 31, 2025 375.00
Dec 31, 2024 -5.00
Sep 30, 2024 779.00
Jun 30, 2024 -829.00
Mar 31, 2024 62.00
Dec 31, 2023 79.00
Sep 30, 2023 1,177.00
Jun 30, 2023 -1,135.00
Mar 31, 2023 2,404.00
Dec 31, 2022 -1,834.00
Sep 30, 2022 96.00
Jun 30, 2022 413.00
Mar 31, 2022 715.00
Dec 31, 2021 -613.00
Sep 30, 2021 126.00